Abstract TP3: Safety of Tenecteplase in Stroke Mimic

医学 特奈特普酶 冲程(发动机) 溶栓 心脏病学 心肌梗塞 机械工程 工程类
作者
A. Shaun Rowe,Brian Wiseman,Leslie A. Hamilton,Sarah Crowell,Lillian McCampbell,D Williams
出处
期刊:Stroke [Lippincott Williams & Wilkins]
卷期号:56 (Suppl_1)
标识
DOI:10.1161/str.56.suppl_1.tp3
摘要

Introduction: Thrombolysis is the gold standard of treatment for acute ischemic stroke, but it must be administered within a narrow time window. This urgency requires healthcare providers to make swift treatment decisions, even when other diagnoses might explain stroke-like symptoms. While treatment with alteplase has been shown to be safe in stroke mimics, the safety of tenecteplase (TNK) in stroke mimics remains unknown. Therefore, our objective was to evaluate the safety of TNK in patients with stroke-like symptoms with and without a confirmed stroke diagnosis. Methods: This was a retrospective cohort study comparing those with acute ischemic stroke (AIS), defined as an ischemic stroke diagnosis on discharge, and those with a stroke mimic, those without an ischemic stroke diagnosis on discharge. Consecutive patients admitted between June 1, 2020, and June 30, 2023, were screened for inclusion in the study. Those patients less than 18 years old, without neuroimaging within 24 hours of TNK administration, who received TNK for an indication other than acute ischemic stroke, and who received mechanical thrombectomy were excluded from the trial. The primary outcome was symptomatic intracranial hemorrhage as defined by the ECAS III criteria. Secondary outcomes included major systemic hemorrhage, minor systemic hemorrhage, asymptomatic intracranial hemorrhage, length of stay, angioedema, and discharge disposition. Results: A total of 250 patients were included in the study. Of those 174 were in the AIS group and 76 in the stroke mimic group. Those in the AIS group were older (69 [13.8] vs. 62.3 [16.1]; p=0.0008), but otherwise were similar with regards to baseline demographics. There was no statistical difference in symptomatic intracranial hemorrhage when comparing the AIS and mimic groups (5 [2.9%] vs. 0 [0%]; p=0.3267); however, there was a statistically higher proportion of patients who experienced an asymptomatic intracranial hemorrhage in the AIS group (15 [8.6%] vs. 0 (0%); p=0.0067). In addition, those in the AIS group had a longer median length of stay as compared to the mimic group (3 days [2 days, 6 days] vs. 2 days [2 days, 4 days]; p=0.0018). There were no statistical differences in major systemic hemorrhage, minor systemic hemorrhage, angioedema, or discharge disposition. Conclusion: The use of TNK in patients with a stroke mimic did not result in a statistically higher proportion of patients who experienced a symptomatic intracranial hemorrhage.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Ava的应助被欣灵采纳,获得15
刚刚
科研通AI6.3的应助被LIUDAN采纳,获得10
刚刚
搞怪灯泡发布了新的文献求助30
1秒前
Twinkle发布了新的文献求助10
2秒前
linr_terran发布了新的文献求助10
2秒前
斯文败类的应助被超级无敌采纳,获得30
2秒前
Y元郁Y完成签到,获得积分20
2秒前
leoan完成签到,获得积分0
3秒前
3秒前
3秒前
4秒前
4秒前
wufel2完成签到,获得积分0
4秒前
王不留行完成签到 ,获得积分10
5秒前
学霸业的应助被YYYY采纳,获得10
7秒前
大方酶完成签到,获得积分10
7秒前
木子完成签到,获得积分20
7秒前
万能图书馆的应助被科研小白采纳,获得10
8秒前
科研通AI6.3的应助被向分公司采纳,获得10
8秒前
JJ完成签到,获得积分10
8秒前
8秒前
woli发布了新的文献求助10
8秒前
Jun的应助被Xk采纳,获得10
9秒前
9秒前
9秒前
阔达晓蓝发布了新的文献求助10
10秒前
10秒前
12秒前
丘比特的应助被kalani采纳,获得10
12秒前
EK发布了新的文献求助10
12秒前
上官若男的应助被开心德地采纳,获得10
13秒前
yskm完成签到,获得积分20
13秒前
kkkk完成签到,获得积分10
13秒前
失眠善若完成签到,获得积分10
13秒前
务实的问丝完成签到,获得积分10
13秒前
CipherSage的应助被Aiserlyn采纳,获得30
14秒前
15秒前
6哈发布了新的文献求助10
16秒前
我是老大的应助被开心德地采纳,获得10
16秒前
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8189302
求助须知:如何正确求助?哪些是违规求助? 9576666
关于积分的说明 21849295
捐赠科研通 7787245
什么是DOI,文献DOI怎么找? 3435521
关于科研通互助平台的介绍 2559748
邀请新用户注册赠送积分活动 2482509